aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19
Go back to aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19| Life Technologies Corporation (NASDAQ: LIFE) | Delayed: 42.02 +2.17 (5.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.85 | 52 Week High | $10.93 | |||
| Open | $39.76 | 52 Week Low | $2.48 | |||
| Day High | $42.55 | P/E | 15.51 | |||
| Day Low | $39.67 | EPS | $2.71 | |||
| Volume | 1,466,054 | |||||
